• 2003

Company Description

Epixis SA, a biotechnology company, engages in the development of advanced immuno-therapies based on recombinant virus-like particles

Epixis SA, a biotechnology company, engages in the development of advanced immuno-therapies based on recombinant virus-like particles against hepatitis C. The company was founded in 2003 and is based in Paris, France.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2003
  • Company Website:

  • Company E-mail:

  • Company Address:

    5, rue des Wallons
    Paris
    France
  • CEO:

    • Charlotte Dalba
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits